Sign up to save your podcasts
Or
Share Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Comparison of Dose Escalation Versus Switching to Tirzepatide When Diabetes Control is Inadequate on Dulaglutide
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
View all episodes
By American College of Physicians
4.5
186186 ratings
Dr. Centor discusses outcomes in patients with inadequately controlled type 2 diabetes when the dulaglutide dose is escalated versus switching to tirzepatide.
More shows like Annals On Call Podcast
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
318 Listeners
AFP: American Family Physician Podcast
697 Listeners
JAMA Clinical Reviews
498 Listeners
Diabetes Core Update
106 Listeners
Mayo Clinic Talks
296 Listeners
Frankly Speaking About Family Medicine
259 Listeners
The Curbsiders Internal Medicine Podcast
3,341 Listeners
Core IM | Internal Medicine Podcast
1,149 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
512 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Run the List
247 Listeners
Cardionerds: A Cardiology Podcast
428 Listeners
The Curious Clinicians
370 Listeners